GPR171 and adenosquamous carcinoma: Among NSCLC subtypes, squamous cell carcinoma, bronchioloalveolar carcinoma, adenosquamous carcinoma, and large-cell carcinoma exhibited a relatively high frequency of positive immunostaining for GPR171 (Supplementary Table 1), whereas mucoepidermoid carcinoma did not.